Circulating microRNAs in maternal blood as potential biomarkers for fetal hypoxia in-utero

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Whitehead, Clare L ^a   Teh, Wan Tinn ^b   Walker, Susan P ^b   Leung, Cheryl ^c   Larmour, Luke ^c   Tong, Stephen ^a  

^a MERCY HOSPITAL FOR WOMEN   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA;

BLOOD; COHORT ANALYSIS; FEMALE; FETAL HYPOXIA; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LABOR; PLACENTA INSUFFICIENCY; PREGNANCY; PRENATAL DIAGNOSIS; PROCEDURES;

BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; FETAL HYPOXIA; GENE EXPRESSION REGULATION; HUMANS; LABOR, OBSTETRIC; MICRORNAS; PLACENTAL INSUFFICIENCY; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 84894226554     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078487     Document Type: Article

References (40)

1. Smith GC, Fretts RC (2007) Stillbirth. Lancet 370: 1715-1725.
2. Froen JF, Gardosi JO, Thurmann A, Francis A, Stray-Pedersen B (2004) Restricted fetal growth in sudden intrauterine unexplained death. Acta obstetricia et gynecologica Scandinavica 83: 801-807.
3. Marsal K (2009) Obstetric management of intrauterine growth restriction. Best practice & research Clinical obstetrics & gynaecology 23: 857-870.
4. Ounsted M, Moar V, Scott WA (1981) Perinatal morbidity and mortality in small-for-dates babies: the relative importance of some maternal factors. Early human development 5: 367-375.
5. Lawn JE, Cousens S, Zupan J (2005) 4 million neonatal deaths: when? Where? Why? Lancet 365: 891-900.
6. de Vries LS, Jongmans MJ (2010) Long-term outcome after neonatal hypoxicischaemic encephalopathy. Archives of disease in childhood Fetal and neonatal edition 95: F220-224.
7. Baschat AA (2006) Fetal growth disorders. In: James DK SP, Weiner CP, editor. High Risk Pregnancy Management Options. 3rd ed. Pennsylvania: Saunders Elsevier. 240-271.
8. Shen J, Stass SA, Jiang F (2013) MicroRNAs as potential biomarkers in human solid tumors. Cancer letters 329: 125-136.
9. Chim SS, Shing TK, Hung EC, Leung TY, Lau TK, et al. (2008) Detection and characterization of placental microRNAs in maternal plasma. Clinical chemistry 54: 482-490.
10. Chan YC, Banerjee J, Choi SY, Sen CK (2012) miR-210: the master hypoxamir. Microcirculation 19: 215-223.
11. Paiva P, Whitehead C, Saglam B, Palmer K, Tong S (2011) Measurement of mRNA transcripts of very high placental expression in maternal blood as biomarkers of preeclampsia. The Journal of clinical endocrinology and metabolism 96: E1807-1815.
12. White CR, Doherty DA, Henderson JJ, Kohan R, Newnham JP, et al. (2012) Accurate prediction of hypoxic-ischaemic encephalopathy at delivery: a cohort study. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 25: 1653-1659.
13. Trudinger BJ, Giles WB, Cook CM, Bombardieri J, Collins L (1985) Fetal umbilical artery flow velocity waveforms and placental resistance: clinical significance. British journal of obstetrics and gynaecology 92: 23-30.
14. Baschat AA (2011) Neurodevelopment following fetal growth restriction and its relationship with antepartum parameters of placental dysfunction. Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 37: 501-514.
15. Chernausek SD (2012) Update: consequences of abnormal fetal growth. The Journal of clinical endocrinology and metabolism 97: 689-695.
16. Flenady V, Middleton P, Smith GC, Duke W, Erwich JJ, et al. (2011) Stillbirths: the way forward in high-income countries. Lancet 377: 1703-1717.
17. Macones GA, Hankins GD, Spong CY, Hauth J, Moore T (2008) The 2008 National Institute of Child Health and Human Development workshop report on electronic fetal monitoring: update on definitions, interpretation, and research guidelines. Obstetrics and gynecology 112: 661-666.
18. Backe B, Nakling J (1993) Effectiveness of antenatal care: a population based study. British journal of obstetrics and gynaecology 100: 727-732.
19. Baschat AA (2010) Fetal growth restriction - from observation to intervention. Journal of perinatal medicine 38: 239-246.
20. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, et al. (2008) Serum microRNAs are promising novel biomarkers. PloS one 3: e3148.
21. Williams Z, Ben-Dov IZ, Elias R, Mihailovic A, Brown M, et al. (2013) Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations. Proceedings of the National Academy of Sciences of the United States of America 110: 4255-4260.
22. Luo SS, Ishibashi O, Ishikawa G, Ishikawa T, Katayama A, et al. (2009) Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes. Biology of reproduction 81: 717-729.
23. Fu G, Brkic J, Hayder H, Peng C (2013) MicroRNAs in Human Placental Development and Pregnancy Complications. International journal of molecular sciences 14: 5519-5544.
24. Pineles BL, Romero R, Montenegro D, Tarca AL, Han YM, et al. (2007) Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. American journal of obstetrics and gynecology 196: 261 e261-266.
25. Enquobahrie DA, Abetew DF, Sorensen TK, Willoughby D, Chidambaram K, et al. (2011) Placental microRNA expression in pregnancies complicated by preeclampsia. American journal of obstetrics and gynecology 204: 178 e112-121.
26. Mayor-Lynn K, Toloubeydokhti T, Cruz AC, Chegini N (2011) Expression profile of microRNAs and mRNAs in human placentas from pregnancies complicated by preeclampsia and preterm labor. Reproductive sciences 18: 46-56.
27. Wu L, Zhou H, Lin H, Qi J, Zhu C, et al. (2012) Circulating microRNAs are elevated in plasma from severe preeclamptic pregnancies. Reproduction 143: 389-397.
28. Gunel T, Zeybek YG, Akcakaya P, Kalelioglu I, Benian A, et al. (2011) Serum microRNA expression in pregnancies with preeclampsia. Genetics and molecular research : GMR 10: 4034-4040.
29. Mouillet JF, Chu T, Hubel CA, Nelson DM, Parks WT, et al. (2010) The levels of hypoxia-regulated microRNAs in plasma of pregnant women with fetal growth restriction. Placenta 31: 781-784.
30. Chan SY, Loscalzo J (2010) MicroRNA-210: a unique and pleiotropic hypoxamir. Cell cycle 9: 1072-1083.
31. Zhang Y, Fei M, Xue G, Zhou Q, Jia Y, et al. (2012) Elevated levels of hypoxia-inducible microRNA-210 in pre-eclampsia: new insights into molecular mechanisms for the disease. Journal of cellular and molecular medicine 16: 249-259.
32. Muralimanoharan S, Maloyan A, Mele J, Guo C, Myatt LG, et al. (2012) MIR-210 modulates mitochondrial respiration in placenta with preeclampsia. Placenta 33: 816-823.
33. Ishibashi O, Ohkuchi A, Ali MM, Kurashina R, Luo SS, et al. (2012) Hydroxysteroid (17-beta) dehydrogenase 1 is dysregulated by miR-210 and miR-518c that are aberrantly expressed in preeclamptic placentas: a novel marker for predicting preeclampsia. Hypertension 59: 265-273.
34. Lee DC, Romero R, Kim JS, Tarca AL, Montenegro D, et al. (2011) miR-210 targets iron-sulfur cluster scaffold homologue in human trophoblast cell lines: siderosis of interstitial trophoblasts as a novel pathology of preterm preeclampsia and small-for-gestational-age pregnancies. The American journal of pathology 179: 590-602.
35. Gorospe M, Tominaga K, Wu X, Fahling M, Ivan M (2011) Post- Transcriptional Control of the Hypoxic Response by RNA-Binding Proteins and MicroRNAs. Frontiers in molecular neuroscience 4: 7.
36. Maccani MA, Padbury JF, Marsit CJ (2011) miR-16 and miR-21 expression in the placenta is associated with fetal growth. PloS one 6: e21210.
37. Ghosh G, Subramanian IV, Adhikari N, Zhang X, Joshi HP, et al. (2010) Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-alpha isoforms and promotes angiogenesis. The Journal of clinical investigation 120: 4141-4154.
38. Crosby ME, Devlin CM, Glazer PM, Calin GA, Ivan M (2009) Emerging roles of microRNAs in the molecular responses to hypoxia. Current pharmaceutical design 15: 3861-3866.
39. Lei Z, Li B, Yang Z, Fang H, Zhang GM, et al. (2009) Regulation of HIF-1alpha and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration. PloS one 4: e7629.
40. Wang W, Feng L, Zhang H, Hachy S, Satohisa S, et al. (2012) Preeclampsia upregulates angiogenesis-associated microRNA (i.e., miR-17, -20a, and -20b) that target ephrin-B2 and EPHB4 in human placenta. The Journal of clinical endocrinology and metabolism 97: E1051-1059.